B. B. Vargaftig

Articles in Scholarly Journals [Incomplete List]

  1. LYMPHATIC THORACIC DUCT LIGATION MODULATES THE SERUM LEVELS OF IL-1?? AND IL-10 AFTER INTESTINAL ISCHEMIA/REPERFUSION IN RATS WITH THE INVOLVEMENT OF TUMOR NECROSIS FACTOR ?? AND NITRIC OXIDE
    Shock, vol. 27, no. 2, pp. 209–213, 2007
  2. Ectopic lung transplantation induces the accumulation of eosinophil progenitors in the recipients' lungs through an allergen- and interleukin-5-dependent mechanism
    Clinical & Experimental Allergy, vol. 37, no. 1, pp. 29–38, 2007
  3. Interference of methysergide, a specific 5-hydroxytryptamine receptor antagonist, with airway chronic allergic inflammation and remodelling in a murine model of asthma
    Clinical & Experimental Allergy, vol. 37, no. 5, pp. 723–734, 2007
  4. Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide
    British Journal of Pharmacology, vol. 148, no. 8, Article ID 0706835, 6 pages, 2006
  5. Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome
    Cytokine, vol. 32, no. 6, pp. 280–286, 2005
  6. Editorial
    Drug Discovery Today: Disease Models, vol. 2, no. 2, pp. iii–iv, 2005
  7. Cells isolated from bone-marrow and lungs of allergic BALB/C mice and cultured in the presence of IL-5 are respectively resistant and susceptible to apoptosis induced by dexamethasone
    International Immunopharmacology, vol. 5, no. 5, pp. 857–870, 2005
  8. Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide- and CD95-dependent pathway
    Nitric Oxide, vol. 11, no. 2, pp. 184–193, 2004
  9. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma
    Nature Medicine, vol. 10, no. 2, Article ID nm983, 3 pages, 2004
  10. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells
    European Journal of Immunology, vol. 34, no. 2, pp. 327–335, 2004
  11. Induction of bone-marrow eosinophilia in mice submitted to surgery is dependent on stress-induced secretion of glucocorticoids
    British Journal of Pharmacology, vol. 143, no. 5, Article ID 0705943, 7 pages, 2004
  12. Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic BALB/c and IL-4Ralpha knockout mice
    Clinical Experimental Allergy, vol. 33, no. 1, pp. 119–131, 2003
  13. Extended freeze-dried Mycobacterium bovis Bacillus Calmette-Guerin induces the release of interleukin-12 but not tumour necrosis factor-alpha by alveolar macrophages, both in vitro and in vivo
    Clinical Experimental Allergy, vol. 33, no. 3, pp. 386–393, 2003
  14. Elicitation of the allergic reaction in beta-lactoglobulin-sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge
    Clinical Experimental Allergy, vol. 33, no. 3, pp. 376–385, 2003
  15. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production
    Immunology, vol. 108, no. 3, pp. 352–364, 2003
  16. Leukotrienes Mediate Murine Bronchopulmonary Hyperreactivity, Inflammation, and Part of Mucosal Metaplasia and Tissue Injury Induced by Recombinant Murine Interleukin-13
    American Journal of Respiratory Cell and Molecular Biology, vol. 28, no. 4, pp. 410–419, 2003
  17. Murine models of asthma
    European Respiratory Journal, vol. 22, no. 2, pp. 374–382, 2003
  18. The Effects of Allergen and Anti-Allergic Drugs on Murine Hemopoietic Cells: Moving Targets, Unusual Mechanisms, and Changing Paradigms
    Current Drug Targets - Inflammation & Allergy, vol. 2, no. 4, pp. 329–337, 2003
  19. Allergenic sensitization prevents upregulation of haemopoiesis by cyclo-oxygenase inhibitors in mice
    British Journal of Pharmacology, vol. 135, no. 5, Article ID 0704580, 8 pages, 2002
  20. Effects of birch pollen and traffic particulate matter on Th2 cytokines, immunoglobulin E levels and bronchial hyper-responsiveness in mice
    Clinical Experimental Allergy, vol. 32, no. 4, pp. 602–611, 2002
  21. Interference of a short-term exposure to nitrogen dioxide with allergic airways responses to allergenic challenges in BALB/c mice
    Mediators of Inflammation, vol. 11, no. 4, pp. 251–260, 2002
  22. EFFECTS OF FRACTIONS OF TRAFFIC PARTICULATE MATTER ON TH2-CYTOKINES, IgE LEVELS, AND BRONCHIAL HYPERRESPONSIVENESS IN MICE
    Journal of Toxicology and Environmental Health Part A, vol. 65, no. 15, pp. 1025–1045, 2002
  23. Increased eosinophil cationic protein levels in bronchoalveolar lavage from wheezy infants
    Pediatric Allergy and Immunology, vol. 12, no. 2, pp. 65–72, 2001
  24. Chronic obstructive pulmonary disease: an old disease with novel concepts and drug strategies
    Trends in Pharmacological Sciences, vol. 22, no. 10, pp. 495–497, 2001
  25. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns
    Vaccine, vol. 19, no. 11-12, pp. 1484–1495, 2001
  26. Endotoxins, asthma, and allergic immune responses
    Toxicology, vol. 152, no. 1-3, pp. 31–35, 2000
  27. Do glucocorticoids enhance eosinopoiesis?
    Trends in Pharmacological Sciences, vol. 21, no. 11, pp. 417–420, 2000
  28. Upregulation by glucocorticoids of responses to eosinopoietic cytokines in bone-marrow from normal and allergic mice
    British Journal of Pharmacology, vol. 129, no. 8, Article ID 0703145, 9 pages, 2000
  29. Murine myeloid progenitor responses to GM-CSF and eosinophil precursor responses to IL-5 represent distinct targets for downmodulation by prostaglandin E2
    British Journal of Pharmacology, vol. 130, no. 6, Article ID 0703403, 6 pages, 2000
  30. Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine
    British Journal of Pharmacology, vol. 126, no. 1, Article ID 0702304, 4 pages, 1999
  31. Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus
    Mediators of Inflammation, vol. 8, no. 1, pp. 17–23, 1999
  32. A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma
    Human Molecular Genetics, vol. 8, no. 4, pp. 601–605, 1999
  33. Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma
    European Respiratory Journal, vol. 13, no. 5, p. 961, 1999
  34. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung
    British Journal of Pharmacology, vol. 123, no. 4, Article ID 0701649, 5 pages, 1998
  35. Correlations between eosionophils and bronchopulmonary hyperreactivity in animal models: role of cytokines by hyper-IgE mice
    Research in Immunology, vol. 149, no. 3, pp. 205–208, 1998
  36. Interleukin-5 modulates interleukin-8 secretion in eosinophilic inflammation
    Mediators of Inflammation, vol. 7, no. 1, pp. 41–47, 1998
  37. Cellular source of human platelet secretory phospholipase A2
    British Journal of Haematology, vol. 100, no. 2, p. 365, 1998
  38. Requirement for T Cells in Allergic Airway Inflammation
    Science, vol. 280, no. 5367, pp. 1265–1267, 1998
  39. Increased spontaneous release of tumour necrosis factor-a by alveolar macrophages from wheezy infants
    European Respiratory Journal, vol. 10, no. 8, pp. 1767–1773, 1997
  40. The LPS-induced neutrophil recruitment into rat air pouches is mediated by TNFalpha: likely macrophage origin
    Mediators of Inflammation, vol. 6, no. 5-6, pp. 335–343, 1997
  41. Stimulation of early eosinophil progenitors by a heat stable alveolar macrophage product from ovalbumin-sensitized and non-sensitized guinea pigs
    Clinical Experimental Allergy, vol. 27, no. 2, pp. 208–217, 1997
  42. Introduction
    Research in Immunology, vol. 148, no. 1, pp. 7–8, 1997
  43. Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages
    Biochemical Pharmacology, vol. 54, no. 9, pp. 1055–1058, 1997
  44. 5-Lipoxygenase and endotoxin-induced microvascular albumin exchanges and leucocyte recruitment in guinea-pig lungs
    European Journal of Pharmacology, vol. 324, no. 1, pp. 89–98, 1997
  45. Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilization and bronchial hyperresponsiveness
    Journal of Allergy and Clinical Immunology, vol. 97, no. 3, pp. 788–799, 1996
  46. Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice
    British Journal of Pharmacology, vol. 120, no. 1, Article ID 0700860, 6 pages, 1996
  47. Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 1300, no. 3, pp. 226–232, 1996
  48. Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice
    Clinical Experimental Allergy, vol. 26, no. 8, pp. 971–979, 1996
  49. Evidence for cAMP-dependent Platelet Ectoprotein Kinase Activity That Phosphorylates Platelet Glycoprotein IV (CD36)
    Journal of Biological Chemistry, vol. 271, no. 40, pp. 24776–24780, 1996
  50. IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome
    Mediators of Inflammation, vol. 5, no. 1, pp. 24–31, 1996
  51. Role of Eosinophil Mobilization and Activation in Experimental Airway Inflammation and Bronchopulmonary Hyperreactivity
    Annals of the New York Academy of Sciences, vol. 796, no. 1 Cytokines and, pp. 72–81, 1996
  52. Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone
    European Respiratory Journal, vol. 8, no. 8, pp. 1321–1327, 1995
  53. Eosinophil Recruitment into the Respiratory Epithelium Following Antigenic Challenge in Hyper-IgE Mice is Accompanied by Interleukin 5-Dependent Bronchial Hyperresponsiveness
    Proceedings of the National Academy of Sciences, vol. 92, no. 26, pp. 12290–12294, 1995
  54. Expression of the Type-II Phospholipase A[IMAGE] in Alveolar Macrophages
    Journal of Biological Chemistry, vol. 270, no. 29, pp. 17327–17332, 1995
  55. Preliminary studies on the hydroalcoholic extract of the root ofCissampelos sympodialis Eichl in guinea-pig tracheal strips and bronchoalveolar leucocytes
    Phytotherapy Research, vol. 9, no. 7, pp. 473–477, 1995
  56. Interference of dexamethasone with leukocyte blood volume and albumin movements in lungs from endotoxemic guinea-pigs
    Pulmonary Pharmacology, vol. 8, no. 6, pp. 289–297, 1995
  57. Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients
    European Journal of Pharmacology, vol. 275, no. 3, pp. 295–300, 1995
  58. Fenspiride: an anti-inflammatory drug with potential benefits in the treatment of endotoxemia
    European Journal of Pharmacology, vol. 294, no. 2-3, pp. 669–676, 1995
  59. Involvement of leukotrienes in allergic imflammation in mice
    European Journal of Pharmacology, vol. 257, no. 3, pp. 211–216, 1994
  60. Excretion of platelet activating factor-acetylhydrolase and phospholipase A into nasal fluids after allergenic challenge: Possible role in the regulation of platelet activating factor release
    Journal of Allergy and Clinical Immunology, vol. 94, no. 1, pp. 109–119, 1994
  61. Nonspecific refractoriness to adenylyl cyclase stimulation in alveolar macrophages from infants with recurrent bronchiolitis
    Journal of Allergy and Clinical Immunology, vol. 93, no. 5, pp. 885–890, 1994
  62. The pharmacology of slow reacting substance C and of arachidonic acid
    Agents and Actions, vol. 43, no. 3-4, pp. 158–167, 1994
  63. Selective synthesis of a secretory phospholipase A2 during adherence of guinea-pig alveolar macrophages
    Agents and Actions, vol. 41, no. S2, pp. C153–C154, 1994
  64. Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 1214, no. 1, pp. 88–96, 1994
  65. Preface
    Annals of the New York Academy of Sciences, vol. 725, no. 1 Cells and Cyt, pp. 1–1, 1994
  66. Modulation by rm Interferon-? and CD4+ T-Lymphocytes of Allergic Eosinophil Accumulation in the Mice Peritoneal Cavity
    Annals of the New York Academy of Sciences, vol. 725, no. 1 Cells and Cyt, pp. 34–43, 1994
  67. Cytokines-Eosinophil Interactions in Experimental Allergy
    Annals of the New York Academy of Sciences, vol. 725, no. 1 Cells and Cyt, pp. 247–258, 1994
  68. Modulation of the Enhanced Migration of Eosinophils from the Airways of Sensitized Guinea Pigs: Role of IL-5
    Annals of the New York Academy of Sciences, vol. 725, no. 1 Cells and Cyt, pp. 274–281, 1994
  69. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways
    Journal of Experimental Medicine, vol. 180, no. 3, pp. 795–805, 1994
  70. Immunoglobulin-G-dependent stimulation of guinea pig lung mast cells and macrophages
    Allergy, vol. 48, no. 8, pp. 608–614, 1993
  71. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation
    European Journal of Biochemistry, vol. 216, no. 1, pp. 169–175, 1993
  72. Lung responsiveness to antigen in sensitised mice of different strains
    Agents and Actions, vol. 38, no. S2, pp. C105–C107, 1993
  73. From lung hypersensitivity to bronchial hyperreactivity What can we learn from studies on animal models
    Biochemical Pharmacology, vol. 45, no. 4, pp. 791–800, 1993
  74. Reduction by arachidonic acid of prostaglandin i2-induced cyclic amp formation Involvement of prostaglandins E2 and F2a
    Biochemical Pharmacology, vol. 45, no. 9, pp. 1815–1820, 1993
  75. Inhibition by nedocromil sodium of recombinant human interieukin-5-induced lung hyperresponsiveness to platelet-activating factor in actively sensitized guinea pigs
    Journal of Allergy and Clinical Immunology, vol. 91, no. 3, pp. 809–816, 1993
  76. Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat (Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. 248 (1993) 27–32)
    European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 248, no. 4, p. 351, 1993
  77. Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat
    European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 248, no. 1, pp. 27–32, 1993
  78. Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat
    European Journal of Pharmacology, vol. 238, no. 1, pp. 47–52, 1993
  79. Interference of PCA 4248, a novel PAF receptor antagonist, with antigen-induced paw edema in mice
    European Journal of Pharmacology, vol. 236, no. 2, pp. 301–304, 1993
  80. Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice
    European Journal of Pharmacology, vol. 235, no. 1, pp. 17–22, 1993
  81. Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor
    European Journal of Pharmacology, vol. 235, no. 1, pp. 101–108, 1993
  82. Differential inhibition by the PAF receptor antagonist, WEB 2170, of allergic inflammation in single sensitized and boosted mice
    European Journal of Pharmacology, vol. 211, no. 1, pp. 29–33, 1992
  83. Pertussis toxin induces bronchopulmonary hyperresponsiveness in guinea-pigs while antagonizing the effects of formyl-L-methionyl-L-leucyl-L-phenylalanine
    European Journal of Pharmacology, vol. 212, no. 2-3, pp. 177–186, 1992
  84. Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs
    European Journal of Pharmacology, vol. 216, no. 2, pp. 141–147, 1992
  85. Interference of antihistamines and anti-allergic drugs with antigen-induced paw edema in boosted and unboosted mice
    European Journal of Pharmacology, vol. 216, no. 3, pp. 429–434, 1992
  86. Interference of azelastine with anaphylaxis induced by ovalbumin challenge in actively sensitized rats
    European Journal of Pharmacology, vol. 213, no. 2, pp. 183–188, 1992
  87. Suppression by cetirizine of pleurisy triggered by antigen in actively sensitized rats
    European Journal of Pharmacology, vol. 223, no. 1, pp. 9–14, 1992
  88. Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages
    Prostaglandins, vol. 43, no. 5, pp. 457–472, 1992
  89. Activation and damage of cultured airway epithelial cells by human elastase and cathepsin G
    European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol. 228, no. 4, pp. 213–218, 1992
  90. Passive sensitization of guinea-pig lung mast cells and alveolar macrophages with anti-ovalbumin IgG1 and IgG2 antibodies
    Agents and Actions, vol. 36, no. S2, pp. C287–C289, 1992
  91. The metabolism of 1-acyl-PAF in rabbit platelets and its possible interaction with PAF
    Lipids, vol. 26, no. 12, pp. 992–996, 1991
  92. Effect of PAF-acether antagonists on active anaphylactic mouse paw edema
    Lipids, vol. 26, no. 12, pp. 1396–1399, 1991
  93. Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig
    Agents and Actions, vol. 34, no. 1-2, pp. 203–204, 1991
  94. Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma
    Journal of Allergy and Clinical Immunology, vol. 88, no. 3, pp. 322–328, 1991
  95. Éosinophile et PAF-acether
    Revue Française d'Allergologie et d'Immunologie Clinique, vol. 30, no. 2, pp. 77–82, 1990
  96. Participation of PAF-acether in the anaphylactic mice paw edema
    European Journal of Pharmacology, vol. 183, no. 3, pp. 887–888, 1990
  97. Pertussis toxin modulates the bronchopulmonary responses of the guinea-pig
    European Journal of Pharmacology, vol. 183, no. 3, p. 1090, 1990
  98. Endotoxin induces bronchial hyper-resporasiveness in the guinea-pig which may involve platelets
    European Journal of Pharmacology, vol. 183, no. 2, p. 186, 1990
  99. Interference of the PAF antagonist compound PCA 4248 with anaphylaetic and hyperresponsiveness to PAF
    European Journal of Pharmacology, vol. 183, no. 2, p. 187, 1990
  100. Inhibition by azelastine of in vitro lung hyperreactivity in the guinea pig
    European Journal of Pharmacology, vol. 183, no. 2, pp. 216–217, 1990
  101. Selective inhibition of cetirizine of the rat pleural eosinophil accumulation induced by PAF-acether or compound ?
    European Journal of Pharmacology, vol. 183, no. 6, pp. 2246–2247, 1990
  102. A pharmacological analysis of imflammation induced by carrageenan and platelet-activating factor in the mice
    European Journal of Pharmacology, vol. 183, no. 6, p. 2252, 1990
  103. Activation of phospholipase A2 in experimental pleuresy
    European Journal of Pharmacology, vol. 183, no. 6, p. 2253, 1990
  104. Fenspiride interferes with neutrophil migration into the peritoneal cavity induced by endotoxln and activated zymosan
    European Journal of Pharmacology, vol. 183, no. 6, p. 2257, 1990
  105. Utilization of primary cultures of guinea-pig respiratory epithelium to study the mode of action of anti-inflammatory drugs and prostanoids
    European Journal of Pharmacology, vol. 183, no. 4, p. 1188, 1990
  106. Interference of PAF-desensitization with the acute phase of allergic pleurisy in rats: evidence for an anti-inflammatory action of eosinophils
    European Journal of Pharmacology, vol. 183, no. 4, p. 1589, 1990
  107. Antigen-dependent activation of alveolar macrophages from ovalbumin-sensitized guinea-pigs: relevance of the route of administration and the amount of antigen provided
    Clinical Experimental Allergy, vol. 20, no. 6, pp. 693–698, 1990
  108. From anti-asthma drugs to PAF-acether anatagonism and back Present status
    Biochemical Pharmacology, vol. 38, no. 9, pp. 1373–1384, 1989
  109. Phospholipase A2-mediated release of arachidonic acid in stimulated guinea pig alveolar macrophages: Interaction with lipid mediators and cyclic AMP
    Journal of Cellular Biochemistry, vol. 40, no. 2, pp. 157–164, 1989
  110. Prostaglandin E2 an